New study monitors infection risks in cutting-edge blood cancer treatment
NCT ID NCT07609576
First seen May 29, 2026 · Last updated Jun 13, 2026 · Updated 3 times
Summary
This study follows 350 adults with blood cancers like lymphoma or multiple myeloma who are being treated with bispecific antibodies. The goal is to track how often infections occur, what types, and how serious they are. Researchers also want to find out what makes some patients more likely to get infections and how infections affect treatment results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOMA MULTIPLE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Infanta Leonor University Hospital
RECRUITINGMadrid, Madrid, 28041, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Infanta Leonor
RECRUITINGMadrid, Madrid, 28005, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.